Follow-up strategies for patients treated for non-metastatic colorectal cancer

Intensive follow-up vs conventional follow-up for patients with non-metastatic colorectal cancer treated with curative intent: A meta-analysis

“…There were no significant differences between the intensive and conventional follow-up strategies in improving cancer-specific survival and relapse-free survival. These results were consistent with those of prior meta-analyses[ 11 , 41 ]. However, subgroup analyses found that intensive follow-up was associated with poor relapse-free survival when the sample size was ≥ 500 patients.…”

Intensive follow-up vs conventional follow-up for patients with non-metastatic colorectal cancer treated with curative intent: A meta-analysis

“…There were no significant differences between the intensive and conventional follow-up strategies in improving cancer-specific survival and relapse-free survival. These results were consistent with those of prior meta-analyses[ 11 , 41 ]. However, subgroup analyses found that intensive follow-up was associated with poor relapse-free survival when the sample size was ≥ 500 patients.…”

Outcomes of Non-metastatic Colon Cancer: A Single-Center Experience

“…Approximately two-thirds of patients present with early-stage disease and are potentially treatable with surgery, chemotherapy, and/or radiotherapy. Nevertheless, 50%-60% of patients develop recurrence with metastatic disease [11]. These findings are consistent with the recurrencefree survival rates obtained in this study (one, two, and five years: 80.5%, 66.5%, and 57.1%, respectively).…”

Consensus and controversies regarding follow‐up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology

“…The first study, a Cochrane review, included eight randomized controlled trials comparing intensive follow‐up with regular or minimum follow‐up. A significant effect from intensive follow‐up on overall survival was found, but without differences in the absolute number of recurrences or disease‐specific survival . The same accounts for the meta‐analysis performed by Tjandra et al .…”

“…Highest level referred to in the guidelines: 1a . The evidence supports the conclusion, since it states that the use of liver imaging seems to be associated with improved survival.…”

Intensive follow-up vs conventional follow-up for patients with non-metastatic colorectal cancer treated with curative intent: A meta-analysis

“…There were no significant differences between the intensive and conventional follow-up strategies in improving cancer-specific survival and relapse-free survival. These results were consistent with those of prior meta-analyses[ 11 , 41 ]. However, subgroup analyses found that intensive follow-up was associated with poor relapse-free survival when the sample size was ≥ 500 patients.…”

Outcomes of Non-metastatic Colon Cancer: A Single-Center Experience

“…Approximately two-thirds of patients present with early-stage disease and are potentially treatable with surgery, chemotherapy, and/or radiotherapy. Nevertheless, 50%-60% of patients develop recurrence with metastatic disease [11]. These findings are consistent with the recurrencefree survival rates obtained in this study (one, two, and five years: 80.5%, 66.5%, and 57.1%, respectively).…”

Consensus and controversies regarding follow‐up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology

“…The first study, a Cochrane review, included eight randomized controlled trials comparing intensive follow‐up with regular or minimum follow‐up. A significant effect from intensive follow‐up on overall survival was found, but without differences in the absolute number of recurrences or disease‐specific survival . The same accounts for the meta‐analysis performed by Tjandra et al .…”

“…Highest level referred to in the guidelines: 1a . The evidence supports the conclusion, since it states that the use of liver imaging seems to be associated with improved survival.…”

Intensive follow-up vs conventional follow-up for patients with non-metastatic colorectal cancer treated with curative intent: A meta-analysis

“…There were no significant differences between the intensive and conventional follow-up strategies in improving cancer-specific survival and relapse-free survival. These results were consistent with those of prior meta-analyses[ 11 , 41 ]. However, subgroup analyses found that intensive follow-up was associated with poor relapse-free survival when the sample size was ≥ 500 patients.…”

Outcomes of Non-metastatic Colon Cancer: A Single-Center Experience

“…Approximately two-thirds of patients present with early-stage disease and are potentially treatable with surgery, chemotherapy, and/or radiotherapy. Nevertheless, 50%-60% of patients develop recurrence with metastatic disease [11]. These findings are consistent with the recurrencefree survival rates obtained in this study (one, two, and five years: 80.5%, 66.5%, and 57.1%, respectively).…”

Consensus and controversies regarding follow‐up after treatment with curative intent of nonmetastatic colorectal cancer: a synopsis of guidelines used in countries represented in the European Society of Coloproctology

“…The first study, a Cochrane review, included eight randomized controlled trials comparing intensive follow‐up with regular or minimum follow‐up. A significant effect from intensive follow‐up on overall survival was found, but without differences in the absolute number of recurrences or disease‐specific survival . The same accounts for the meta‐analysis performed by Tjandra et al .…”

“…Highest level referred to in the guidelines: 1a . The evidence supports the conclusion, since it states that the use of liver imaging seems to be associated with improved survival.…”